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Abstract
Introduction: Laryngeal involvement in rheumatoid arthritis is a 
rarely mentioned complication in clinical practice. In the literature 
over the last 10 years, single articles on the subject have been 
published, presenting a small number of clinical cases. Cricoarytenoid 
arthritis is a life-threatening condition requiring timely anesthesia and 
otorhinolaryngological intervention, where the tracheostomy has an 
important therapeutic place.
Aim: With the presentation of our clinical case we aim to expand 
the knowledge about systemic diseases and their possible acute 
manifestation in otorhinolaryngological practice.
Materials and methods: We present a clinical case of patient M.S., 
63 years old, female, with a long medical history of rheumatoid 
arthritis. She was admitted to the clinic with a tracheostomy cannula 
placed for acute laryngeal dyspnea. Physical examination with 
a fibrolaryngoscope revealed bilateral paresis of the vocal folds, 
in a medial position, without phonatory and respiratory activity. 
Computer tomography of the neck, chest, with a focus on the 
mediastinum – without clinical data on tumor processes. Laboratory 
tests reveal a repeatedly elevated rheumatoid factor.
Results: MRI revealed a collapse of the larynx, with pronounced 
fatty degeneration of the thyroarytenoid and cricoarytenoid muscles. 
The patient was referred to a rheumatologist to control the chronic 
exacerbation process, with a definitive tracheostomy cannula.
Conclusion: Pathological changes in the cricoarytenoid joint in 
patients with rheumatoid arthritis, as well as scleroderma, lupus, 
Felty’s syndrome, Tiez syndrome and other systemic diseases, are a 
common finding, although diagnosed in the past at autopsy. It can be 
acute, subacute and chronic, but in otorhinolaryngological practice it 
occupies an important clinical place in emergencies.
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Introduction
Rheumatoid arthritis (RA) is a chronic inflammato-
ry joint disease that involves the cartilage and bone 
of small and medium-sized joints, the main clinical 
manifestation of which is erosive-destructive pro-
gressive polyarthritis. May affect extra-articular 
tissues and organs.
Rheumatoid arthritis is one of the most common 
rheumatic diseases. It affects about 1% of the 
world’s population with certain regional differenc-
es. In southern European countries, an average of 
3 per 10,000 people are affected, and in northern 
European countries the incidence is 5 per 10,000. 
The female / male ratio is 6/1 to 60 years of age, 
with the incidence equalizing that age.
The etiopathogenesis of rheumatoid arthritis is 
unclear. Its occurrence is determined by the interac-
tion of genetic, immunological and environmental 
factors. It is an immune dysregulation that leads to 
chronic inflammation and causes organ disorders, 
increased morbidity and mortality. One of the most 
important signs of immune dysregulation is the 
activation of inflammatory cytokines, such as IL10, 
IL6 or TNF-alpha. Their effects lead to pathologi-
cal changes.
The temporomandibular joint, larynx, cervical 
spine and audiovestibular system are sites of 
involvement in the head and neck region of patients 
with RA.6
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In RA, the larynx is involved in 27-80.9% of 
patients, varying in different studies 2,3,4. Its 
involvement in the early course of the disease is in 
most cases underestimated due to the prevalence 
of systemic manifestations, inconspicuous clinical 
findings on the part of the larynx and non-specific 
symptoms. 
Laryngoscopic examination may not reveal any 
findings, but mucosal edema and diffuse or local-
ized inflammation may also be seen. Other laryn-
goscopic findings of laryngeal involvement include 
cricoarytenoid joint involvement, interarytenoid 
fibrosis, vocal cord paralysis, and rheumatoid nod-
ule formation.7
Patients with RA are subject to screening for laryn-
geal involvement, using subjective and objective 
methods. A subjective VHI (voice handicap index) 
questionnaire and objective acoustic sound analysis 
are used in the diagnostic algorithm.
As the disease progresses, acute airway obstruction 
may occur, which is a life-threatening condition 
requiring timely anesthesia and otorhinolaryngo-
logical intervention, where the tracheostomy occu-
pies an important clinical place.
Material and methods
This is a 63-year-old woman diagnosed with sero-
positive RA in 2004. She underwent sequential 
treatment with a synthetic pathogen Methotrexate 
10 mg. weekly, biological disease-modifying anti-
rheumatic agents (Remicade, Humira, RoАctemra) 
and last with Clisia until 2018, when therapy was 
discontinued due to the appearance of Herpes Zos-
ter.
The patient was admitted to the clinic with a tra-
cheostomy cannula placed on the occasion of acute 
laryngeal dyspnea in another hospital. There is 
a history of intermittent voice loss and difficulty 
eating solid foods.
As concomitant diseases – Rheumatoid arthritis, 
Gastric ulcer, Iron deficiency anemia, Struma 
nodosis.
To make the diagnosis, the following tests were 
performed – complete blood count, general phys-
ical (Fig. 1) and otorhinolaryngological examina-
tion, fibrolaryngoscopy, computed tomography, 
magnetic resonance imaging.
Results
Indirect laryngoscopy and fibrolaryngoscopy – bilat-
eral paresis of the vocal cords, in the medial posi-
tion, without phonatory and respiratory activity.
From blood tests – CBC – Anemic syndrome; no 
leukocytosis; thrombocytosis; ESR – 77 mm / h; 
CRP – 55 mg / L, multiple rheumatoid factor – RF 
– 1881.4 IU / ml (0-20)
CT of the neck and chest was performed, focusing 
on the mediastinum – without clinical evidence of 
a tumor process (Fig. 2).
Fig.1. The physical examination reveals deformation and 
swelling of  the metacarpophalangeal joints and limited 
mobility of  the elbow joints, wrists, knees and ankles.
Fig. 2. CT finding for the presence of  calcifications in the 
area of  the arytenoids
Fig. 3. MRI reveals collapse of  the larynx with 
pronounced fatty degeneration of  the thyroarytenoid and 
cricoarytenoid muscles
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The patient was referred to a rheumatologist to 
control the chronic exacerbation process, with a 
definitive tracheostomy cannula.
The possibility of performing an arytenoidectomy 
was not excluded in the discussion of the patient’s 
therapeutic behavior.
Discussion
Involvement of the larynx in rheumatoid arthritis 
was first described by Sir Morell MacKenzie in 
1880.1.
Grosmann et al. reported that five of 11 RA patients 
had laryngeal involvement in post-mortem exam-
ination and only two of them were symptomatic. 
They found that half patients with RA had laryn-
geal symptoms 5. Similarly, several studies have 
reported that up to 50% of patients are having 
laryngeal involvement as the sole manifestation of 
this disease.9,10
Pathological changes in the cricoarytenoid joint 
are most common in patients with rheumatoid 
arthritis, but can also occur in other conditions such 
as scleroderma, lupus, gout, Tiez syndrome, Felty 
syndrome.
Laryngoscopic findings in RA may also include 
the presence of Bamboo nodes. Bamboo nodes 
were initially described by Hosako et al. in a 
female patient with lupus erythematous. Endoscop-
ic visualization shows transversally arranged cystic 
yellowish bamboo nodes in the submucosal space 
of the middle portion of the vocal folds. Similar 
to other laryngeal lesions in patients with RA, 
these nodes are more often seen in patients with 
active disease rather than inactive and correlates 
with antibody deposits 11, These lesions are seen 
more commonly in females with history of pho-
notraumatic behavior and gastroesophageal reflux 
disease.
In patients with long-standing rheumatoid arthritis, 
signs of laryngeal involvement may go unnoticed, 
especially with slow progression.
There are several possible causes for the develop-
ment of fibrosis and ankylosis of the joint.
The impaired movement may be in the vertical, 
anteroposterior, or mediolateral directions.
Histopathologic findings vary from inflammatory 
changes to synovial proliferation and destruction 
of the articular cartilage, with or without pannus. A 
second cause for the impaired mobility of the vocal 
folds is the presence of rheumatoid nodule in either 
the vocalis muscle and/or near the CAJ hindering 
its mobility. Erbet al. have shown the presence of 
these confluent nodules in conjunction with inflam-
mation of the synovial joints, destruction of the 
laryngeal cartilages, and impinging on the airway12. 
A third cause for the impaired mobility is abductor 
muscle paralysis. Darke et al. have reported the 
presence of severe demyelination and degeneration 
of the recurrent laryngeal and vagus nerves togeth-
er with atrophy of the 
laryngeal muscles with or without obliterative 
arteritis of the vasa vasorum13. A fourth possible 
etiology is cervicomedullary compression due to 
rheumatoid involvement of the cervical spine. Link 
et al. have reported this often overlooked cause of 
vocal fold palsy in patients with RA14 .Watkinson 
has also described laryngeal amyloidosis as a rare 
cause of stridor in patients with RA.
Complications of RA may begin to develop within 
a few months of the onset of clinical symptoms 
such as acute respiratory failure may be provoked 
by bacterial infections of the larynx, mechanical 
lesions of the larynx, or exacerbation of cricoary-
tenoid arthritis.
Pathological changes in patients with RA create 
difficulties and pose a risk in endotracheal intuba-
tion, which in turn suggests the need for an oto-
laryngologist and anesthesiologist, with an assess-
ment of performing a tracheostomy.





•  Feeling of  a foreign body 
in the throat
• Tension in the neck
• Hoarse voice
• Odynophagia
• Odino / Dysphagia
• Otalgia
• Shortness of  breath
• Cough
• Hoarse voice
• Stridor on exertion
• Shortness of  breath
• Odinophony
• Swelling of  the neck
Treatment
A multidisciplinary approach involving a rheuma-
tologist, ENT and rehabilitator is needed. 
The main principles of treatment are:
•  Active treatment in patients with poor prognosis 
– those with polyarticular involvement, progres-
sive course and high rheumatoid factors.
•  The basic agents Methotrexat and Sulphsalazine 
are preferred.
• Kerstens et al. have reported accelerated nodu-
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Table 2. Clinical signs of  cricoarytenoid joint involvement.













• Foreign body sensation
• Globus pharyngeus
Airway symptoms
• Shortness of  breath







•  Impaired mobility of  the vocal fold





•  Density changes in CAJ* and/or 
CTJ*
•  Volume changes in CAJ and/or CTJ
•  Soft tissue changes in CAJ or CTJ
• Erosion of  the CAJ or CTJ
• Ankylosis of  the CAJ or CTJ
*CAJ: cricoarytenoid joint. *CTJ: cricothyroid joint
Hamdan AL, Sarieddine D. Laryngeal manifestations of  rheumatoid arthritis. Autoimmune Dis. 2013; 103081
losis in 5–10% of patients with RA treated with 
low-dose methotrexate therapy15.With respect to 
the Bamboo nodes, these lesions may be treated 
either surgically or conservatively. Hilgert et 
al. favor conservative approach to these lesions 
and have reported good outcome with logopedic 
therapy 16
•  Biological agents are used for those who are not 
affected by the basic medications.
 Patients with RA diagnosed with cricoarytenoid 
involvement usually do not require additional 
treatment.
• Some authors reported administration of high 
doses of steroids systemically or locally into the 
cricoarytenoid joint. Injection of the cricoaryt-
enoid joint with steroid may be an adjunctive 
procedure to parental corticosteroid therapy14
• In cases of acute respiratory distress of life 
threatening emergencies, a tracheostomy should 
be performed to secure the airway.
Conclusion
RA is a systemic autoimmune disease with wide-
spread clinical manifestations. Otolaryngologi-
cal signs and symptoms are variable and may 
not always be properly defined. The appearance 
of even discrete upper respiratory symptoms in 
patients with RA should sharpen the clinician’s 
attention to engaging the laryngeal structures.
In these cases, a thorough examination of the ENT 
organs is recommended in order to exclude cricoar-
ytenoid pathology.
A multidisciplinary approach is needed to ensure 
adequate laryngeal rehabilitation and alleviate the 
patient’s suffering.
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